Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Have not checked for awhile. I'll reach out...
Hawk
Like news and move, hate the GAP...
Hawk
This would be a Good time for some Real news for us all.
Updates please...
Hawk
Came down to last holes for many of us. Fun this time...
Hawk
Top 6 here very close this time....Fun,
Hawk
Winged Foot wakes up today !!...
Play on.
Hawk
Fowler playing well...because he cut off that stash ?!
Hawk
DJ, Schauffele, Simpson, Berger, DeChambeau.....278
Begins Now.....
Hawk
Should see Real news soon now..!
Hawk
Not anymore...
Scheffler WD from U.S. Open due to positive COVID-19 test
My mistake...forgot that Rule for a moment....
Hawk
Bid/Ask looks good for the Open today...
Hawk
Wall at 29 area yesterday...need to PUSH through on charts..
Hawk
God help U if U miss a fairway today...
Hawk
1 uner best so far...3 guys 1 under. Course set up still Winning.
Hawk
Love to pick Day, but never know when his Back is Bad...same as Tiger.
Hawk
Jason's Back must be OFF just a bit again....
Hawk
Look at the radar today...came through here last night..MN
See how much they get in today...
Hawk
Filled the Gap, now go time...
Hawk
Course set up is Winning.
These guys R having a tough time. Miss the short grass and U R
in trouble...
Hawk
Yep..they let it grow like US Open....
Hawk
BUX...any comments ??!
Hope someone knows something...
News soon on lawsuits ?!
Hawk
Rory has lost his Driver. 2 triples already today....ouch.
Hawk
Replace Koepka w/ Niemann
JT, McILoy, DJ, Hatton, Finau, Hovland, Cantley, Day, Casey, Koepka.
Biocept Reports Second Quarter 2020 Financial Results
August 12 2020 - 04:05PM
PR Newswire (US)
Alert
Print
Share On Facebook
SAN DIEGO, Aug. 12, 2020 /PRNewswire/ -- Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular technologies designed to provide physicians with clinically actionable information to improve the outcomes of patients, reports financial results for the three and six months ended June 30, 2020 and provides an update on its business progress.
Biocept Logo (PRNewsFoto/Biocept, Inc.)
"Due to our decision to initiate COVID-19 testing, overall commercial volume during the second quarter increased slightly versus the prior year, even with the impact of the pandemic," said Michael Nall, President and CEO of Biocept. "Commercial volume in our core oncology business was down 16% year-over-year, which is significantly better than the decline of up to 40% we anticipated in our second quarter forecast. We reached a low point in oncology testing early in the second quarter, with subsequent improvement as the quarter progressed. However, with the resurgence of the pandemic, physicians report that patient office visits have not returned to pre-COVID levels, which is continuing to affect our oncology testing volume. In addition to the launch of our COVID-19 testing service, our better-than-expected performance was driven in part by new assays that evaluate the cerebrospinal fluid of patients with breast or lung cancer suspected of brain or central nervous system metastases. Revenues for the quarter decreased 23% year-over-year, as a result of fewer patient visits to physician offices attributed to the concerns about COVID 19. That said, revenues for the first half of 2020 were up 7% over the prior year, driven by our strong first quarter performance before the full impact of the pandemic.
"For the immediate future, COVID-19 testing is an important part of our business and I'm pleased to report that we have received over 11,000 specimens to date," he added. "We have secured components to date for approximately 50,000 COVID-19 specimen collection kits to support current testing and expect to begin shipping our own COVID-19 specimen collection kits to our lab services customers later this year, which will contain our proprietary VEE-SURE™ viral transport media. These kits will be available for use in our lab or can be sold to other labs. We are excited about our recent development agreement with Aegea Biotechnologies to utilize Switch-Blocker™ technology to develop tests that could increase sensitivity in detecting SARS-CoV-2, the virus that causes COVID-19, and provide additional information on specific strain types.
"We are proud to support public health efforts by offering COVID-19 testing and plan to develop and offer these critical products and services for as long as they are needed," said Mr. Nall. "As a long-term strategy, we remain focused on oncology and believe we are well positioned to weather the pandemic as we continue to make progress on multiple aspects of our core business and build for a strong future. We are an established leader in liquid biopsy with our Target Selector™ assays, providing information that is critical to physician decision-making for their patients diagnosed with cancer. We expect that when the pandemic subsides, our commercial oncology volume will return to growth. We believe our recently strengthened balance sheet will support this strategy."
Look at the Daily charts guys. Learn how to read these.
Hawk
Finish the Gap than turning...
Transocean Ltd. Announces Exchange Offers and Consent Solicitations for certain Existing Notes
August 10 2020 - 06:46PM
GlobeNewswire Inc.
Alert
Print
Share On Facebook
Transocean Ltd. (NYSE: RIG) announced today that Transocean Inc., its wholly-owned subsidiary (collectively with Transocean Ltd., “Transocean”), has commenced exchange offers (the “Exchange Offers”) to exchange the existing notes listed below (the “Existing Notes”) for up to an aggregate principal amount of $750,000,000 (subject to increase or decrease by Transocean Inc., the “Maximum New Notes Amount”) of the applicable series of new notes (the “New Senior Guaranteed Notes”) issued by Transocean Inc.
The New Senior Guaranteed Notes will be guaranteed by Transocean Ltd. and three indirect holding company subsidiaries of Transocean Inc.: Transocean Mid Holdings 1 Limited (“Mid Holdings 1”), Transocean Mid Holdings 2 Limited (“Mid Holdings 2”) and Transocean Mid Holdings 3 Limited (“Mid Holdings 3”, and collectively with Mid Holdings 1 and Mid Holdings 2, the “Structurally Senior Guarantors”). The Structurally Senior Guarantors are owned by Transocean Holdings 1 Limited, Transocean Holdings 2 Limited and Transocean Holdings 3 Limited which, following Transocean’s previously announced internal reorganization transactions, will continue to own, directly or indirectly, all of the outstanding equity interests of the other subsidiaries of Transocean Inc., including Transocean Asset Holdings 1 Limited, Transocean Asset Holdings 2 Limited and Transocean Asset Holdings 3 Limited.
Should be a great WK coming up. Pile of news ready soon for us all....
Hawk
Looks like a Big Ask now. Even BUX has vanished some time ago. Hard to Pump anymore. Get some real News out and people might return...
Hawk
Stock moves....
Hawk
That last 2 hrs of play killed me. My Team can't play late day golf . West Coast.
Hawk
What happened to Kaymer yesterday ?!! clunk !
Hawk
Not me...out of this Bag. Too long. No good news to see....
GLA left
Hawk
Day 1 was fun. Let's get it today...
Hawk